KWS BioTest is now a part of Charles River

In January 2018, Charles River acquired KWS BioTest, a leading contract research organization (CRO) located in Portishead, UK, specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The addition of KWS BioTest’s world-leading immunology expertise makes additional tools available in the increasingly active and promising therapeutic research areas of immunology, oncology, and autoimmune and infectious disease.

If you're ready to discuss a project or have questions, contact us

KWS BioTest logo

Areas of Expertise

Immune responses are involved in nearly every disease area, and there is increasing recognition that the field of immunology intersects with and will open new treatment avenues in many therapeutic areas. If you have a molecule that touches the immune system, we can help. Our areas of expertise include:

Specialised Capabilities

Specialising in all areas of immunology, with experience testing small molecules, biologics, ADCs and vaccines, KWS BioTest solutions often feature bespoke study designs tailored to meet specific program requirements. Whether working with KWS BioTest alone, or in concert with other Charles River Centers of Excellence, we assist in the design and interpretation of complex programs in target validation, lead optimisation, candidate selection, discovery support, and clinical sample analysis, increasing the chance of molecules succeeding and helping bring them to the clinic faster. Our expanded range of in vivo pharmacology models can assist the efficacy evaluations of your compounds (e.g., infectious disease, inflammation and immunology, ocular disease, SLE). KWS BioTest’s specialised capabilities complement Charles River's services by providing: